Nephros (NEPH) Shares Outstanding (Weighted Average) (2010 - 2026)

Nephros has reported Shares Outstanding (Weighted Average) for 17 years, with the latest figure at $10.7 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding (Weighted Average) changed 0.48% year-over-year to $10.7 million; the trailing twelve-month figure through Mar 2026 stood at $10.7 million (changed 0.48% YoY), and the FY2025 full-year result was $10.6 million, up 0.83% from the prior year.
• Shares Outstanding (Weighted Average) for Q1 2026 stood at $10.7 million, roughly flat from $10.6 million in the prior quarter.
• The five-year high for Shares Outstanding (Weighted Average) was $10.7 million in Q1 2026, with the low at $10.2 million in Q1 2022.
• Average Shares Outstanding (Weighted Average) over 5 years is $10.5 million, with a median of $10.5 million recorded in 2024.
• Year-over-year, Shares Outstanding (Weighted Average) climbed 3.48% in 2022 and rose 0.48% in 2026.
• Tracing NEPH's Shares Outstanding (Weighted Average) over 5 years: stood at $10.3 million in 2022, then gained by 0.8% to $10.4 million in 2023, then climbed by 1.34% to $10.5 million in 2024, then climbed by 0.83% to $10.6 million in 2025, then gained by 0.36% to $10.7 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $10.7 million (Q1 2026), $10.6 million (Q4 2025), and $10.6 million (Q3 2025), per Business Quant data.

Peer Comparison